Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
2024-2033 Exosome Diagnostic And Therapeutic Market Growth Rate: What’s the Forecast?
The market size of exosome diagnostic and therapeutic services has seen substantial growth in the past few years. The market is projected to expand from $0.36 billion in 2023 to $0.48 billion in 2024, with a compound annual growth rate (CAGR) of 31.1%. The massive growth during the historic period is a result of several factors, including advancements in biological research, the advent of precision medicine, breakthroughs in biomedical imaging, progress in cancer research and oncology, as well as investments from the healthcare industry.
Anticipated to experience a significant surge in the coming years, the exosome diagnostic and therapeutic market is set to increase to $1.28 billion by 2028, boasting a compound annual growth rate (CAGR) of 28.1%. This development during the prediction period can be credited to several factors such as the augmentation of its clinical applications, the combination with digital health technologies, a conducive regulatory environment, advancements in gene editing and RNA therapeutics, along with its broadening scope in immuno-oncology. Noteworthy trends for the forecast period encompass discovery of drugs based on exosome, biomimetic exosome engineering, marketing of exosome products, therapeutic cargo loaded with exosomes and use of liquid biopsy for cancer detection.
Claim Your Free Sample of the Global Exosome Diagnostic And Therapeutic Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12346&type=smp
What Drivers Are Accelerating the Growth of the exosome diagnostic and therapeutic Market?
The escalating occurrence of chronic ailments is anticipated to stimulate the expansion of the exosome diagnostic and therapeutic market in the future. Chronic diseases are typically enduring illnesses that prolong over three months or more, with the potential to worsen over time. The diagnostic and therapeutic utilities of exosomes serve as potential biomarkers in cancer, offering more precise disease tracking and making individualized medicine more attainable. As an example, the National Center for Biotechnology Information (NCBI), a United States-based National Library of Medicine, projected in January 2023 that by 2050, the global population of people afflicted with chronic diseases will reach 142.66 million. As a result, the escalating incidence of chronic diseases is steering the growth of the exosome diagnostics and therapeutics market.
What Key Segments Can Be Identified in the Exosome Diagnostic And Therapeutic Market?
1) By Product: Instruments, Software, Reagents And Kits
2) By Application: Diagnostics, Therapeutic
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users
What Trends Are On the Rise in the Exosome Diagnostic And Therapeutic Market?
Leading firms in the exosome diagnostic and therapeutic industry are introducing innovative product solutions like sample purification systems, to appeal to a broader customer range, boost product sales, and escalate their revenue. A sample purification system encompasses a chain of processes and tools used for the elimination of impurities and contaminants from a sample, potentially consisting of DNA, RNA, proteins, or other biomolecules. For instance, in February 2023, Biological Dynamics Inc., a US-based biotech firm, rolled out ExoVerita, a platform engineered for exosome isolation for early disease identification and more. The ExoVita Pancreas test detects specific exosomal protein markers and can identify Stage 1 and Stage 2 pancreatic ductal adenoma carcinoma (PDAC) using blood-derived exosome samples enriched on the proprietary ExoVerita device. Biological Dynamics Inc. anticipates leveraging this validation to evaluate samples from the ExoLuminate registry trial (NCT05625529), which is currently onboarding patients with high-risk PDAC for assessing the clinical relevance of the test. Eligibility criteria extend to patients displaying clinical symptoms such as pancreatitis or identifiable pancreatic lesions, individuals genetically or familially predisposed, and newly diagnosed diabetics over 50.
Order Now for Fast Delivery of Your Exosome Diagnostic And Therapeutic Market Report!
What Regions Are Steering Growth in the Exosome Diagnostic And Therapeutic Sector?
North America was the largest region in the exosome diagnostic and therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Exosome Diagnostic And Therapeutic Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the exosome diagnostic and therapeutic market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Exosome Diagnostic And Therapeutic Market Include
1. Exosome Diagnostic And Therapeutic Market Executive Summary
2. Exosome Diagnostic And Therapeutic Market Segments
3. Exosome Diagnostic And Therapeutic Market Size And Template Market Growth Rate
4. Key Exosome Diagnostic And Therapeutic Market Trends
5. Major Exosome Diagnostic And Therapeutic Market Drivers
……
25. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market
26. Top Exosome Diagnostic And Therapeutic Companies
27. Exosome Diagnostic And Therapeutic Market Opportunities And Strategies
28. Exosome Diagnostic And Therapeutic Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
3D Diagnostic Imaging Services Global Market Report 2024
Diagnostic Imaging Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report
Dental Diagnostic Imaging Devices And Equipment Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
